From: KIR repertory in patients with hematopoietic diseases and healthy family members
All | AML | p-value | ||
---|---|---|---|---|
KIR GENE | (n = 12) | (n = 11) | ||
Framework | KIR2DL4 | 12 (100 %) | 11 (100 %) | 1.0000 |
KIR3DL2 | 12 (100 %) | 11 (100 %) | 1.0000 | |
KIR3DL3 | 12 (100 %) | 11 (100 %) | 1.0000 | |
KIR3DP1 | 12 (100 %) | 11 (100 %) | 1.0000 | |
Haplotype A | KIR2DS4 | 11 (92 %) | 9 (82 %) | 0.5921 |
KIR2DL1 | 11 (92 %) | 8 (73 %) | 0.3168 | |
KIR2DL3 | 11 (92 %) | 9 (82 %) | 0.5901 | |
KIR3DL1 | 12 (100 %) | 10 (91 %) | 0.4783 | |
Haplotype B | KIR2DS1 | 10 (83 %) | 9 (82 %) | 1.0000 |
KIR2DS2 | 3 (25 %) | 3 (27 %) | 1.0000 | |
KIR2DS3 | 2 (17 %) | 9 (82 %) | 0.0031 ( a ) | |
KIR2DS5 | 5 (42 %) | 3 (27 %) | 0.6668 | |
KIR3DS1 | 2 (17 %) | 5 (45 %) | 0.1930 | |
KIR2DL2 | 3 (25 %) | 3 (27 %) | 1.0000 | |
KIR2DL5 | 4 (33 %) | 4 (36 %) | 1.0000 | |
Haplotype A/B | KIR2DP1 | 12 (100 %) | 9 (82 %) | 0.2174 |